Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Meningioma × Clear all

Status

Completed 89 Recruiting 56 Unknown 25 Terminated 18 Not yet recruiting 15 Active not recruiting 13 Withdrawn 7 Suspended 1 Enrolling by invitation 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms 14 Carcinoma, Non-Small-Cell Lung 8 Sarcoma 6 Recurrence 6 Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroblastoma 6 Multiple Myeloma 6 Pancreatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Breast Neoplasms 4 Stomach Neoplasms 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Primary Myelofibrosis 2 Pheochromocytoma 2 Osteosarcoma 2 Non-Muscle Invasive Bladder Neoplasms 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07497984 2026-03-27

ITM11 Expanded Access Program

ITM Solucin GmbH

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡